ABOUT THIS STUDY
- Patients diagnosed as advanced RCC by histology or cytology
- Patients using axitinib as therapy after failure of sunitinib or cytokine
- Patients received axitinib treatment and follow up in the health care center participating present registry
- Patients agree to participate and signed inform consent or IRB waiving of signed informed consent document is available
- Patients with first dose of axitinib earlier than 7th May 2013
- Patients with first dose of axitinib later than 30th June 2015.
- Patients participating in clinical research involving axitinib
- Patients with hypersensitivity to axitinib or to any other component of axitinib
- Patients under 18-year of age
- Pregnant women.
TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Based on your search, you may also be interested in
- New York, New York
- Toronto, Ontario
- Durham, North Carolina